Latest Feature Articles

blockchain-3750157_640

Insider Interview: A roadblock for counterfeit drugs?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Merck KGaA, blockchain, fake drugs, feature, pharma

Dr Thomas Endress, Founder, and Dr Frederic Berkermann, co-?Founder, of a new technology being developed at the Merck Innovation Center …

Living with mal de debarquement syndrome

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | patient experience, pharma, rare disease

Polly Moyer reflects on her experiences living with the rare condition mal de debarquement syndrome, and discusses how connecting with …

shutterstock_158366573

Healthcare communications: Time to think differently with patient centricity

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Spink, patient centricity, pharma

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me”, has been adopted by pharma to understand …

brexit

The Brexit ‘cliff edge’: How life sciences can survive

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | UK, brexit, pharma

Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit …

millerblockchainadj-1600x1200

The missing link: Blockchain in clinical data management

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Big Data, blockchain, data, data management, pharma, supply chain

Louis Goss explores the potential uses for the much-hyped technology blockchain as a tool to tackle the data management challenges …

Implementing “the safest medicines system in the world”

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | feature, packaging, pharma

With debates heating up over cooperation between European across the continent, Matt Fellows investigates the current state of packaging countermeasures …

Battling cervical cancer in the developing world

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Doctors Without Borders, Medecins sans frontieres; cancer, cervical cancer, malawi, pharma

The non-profit humanitarian organization Medecins Sans Frontieres, or Doctors Without Borders, is well known for its work fighting on the …

Working Life: Monika Pocinkova, Vice President, HR Speciality Care, Ipsen UK & Ireland

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Working Life, feature, pharma

Ipsen’s Vice President of HR Speciality Care discusses the path she has taken throughout her career, the cultural differences she …

katy_baker

Living with Scimitar syndrome

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Scimitar syndrome, patient experience, pharma

Katy Baker has lived her entire life with the rare congenital heart defect Scimitar syndrome. She reflects on the system …

Insider Interview: Paving paths in prostate cancer

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, Interview, Janssen, feature, pharma, prostate cancer

Joaquin Casariego Garcia Luben, Medical Affairs Director Europe, Middle East & Africa, Prostate Cancer for Johnson & Johnson (pictured) discusses …

Will mobile phones save the NHS?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | NHS, UK, feature, mhealth, mobile health, pharma

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …

The price of access: Can the NHS afford Orkambi?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Drug pricing, NHS, NICE, Orkambi, UK, Vertex, access, cystic fibrosis, feature, pharma, pricing

The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …

The Gateway to Local Adoption Series

Latest content